Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

AVEO Pharmaceuticals Revenue 2009-2020 | AVEO

AVEO Pharmaceuticals revenue from 2009 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  
AVEO Pharmaceuticals Annual Revenue
(Millions of US $)
2019 $29
2018 $5
2017 $8
2016 $3
2015 $19
2014 $18
2013 $1
2012 $19
2011 $165
2010 $45
2009 $21
2008 $20
AVEO Pharmaceuticals Quarterly Revenue
(Millions of US $)
2020-03-31 $1
2019-12-31 $1
2019-09-30 $26
2019-06-30 $1
2019-03-31 $2
2018-12-31 $1
2018-09-30 $2
2018-06-30 $0
2018-03-31 $1
2017-12-31 $0
2017-09-30 $5
2017-06-30 $0
2017-03-31 $3
2016-12-31 $0
2016-09-30 $1
2016-06-30 $0
2016-03-31 $1
2015-12-31 $4
2015-09-30 $15
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $1
2014-06-30 $2
2014-03-31 $15
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $16
2012-09-30 $1
2012-06-30 $2
2012-03-31 $1
2011-12-31 $1
2011-09-30 $4
2011-06-30 $27
2011-03-31 $134
2010-12-31 $12
2010-09-30 $6
2010-06-30 $16
2010-03-31 $11
2009-12-31 $6
2009-09-30 $6
2009-06-30 $5
2009-03-31 $4
2008-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.070B $0.029B
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company's next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $148.038B 16.30
Bristol Myers Squibb (BMY) United States $131.485B 10.98
Gilead Sciences (GILD) United States $93.714B 12.15
CSL (CSLLY) Australia $88.578B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.590B 52.66
Regeneron Pharmaceuticals (REGN) United States $70.481B 27.17
Illumina (ILMN) United States $54.772B 56.28
Biogen (BIIB) United States $45.480B 7.78
Seattle Genetics (SGEN) United States $31.361B 0.00
Moderna (MRNA) United States $24.118B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.107B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.953B 10.29
Incyte (INCY) United States $23.448B 0.00
Genmab (GMAB) Denmark $23.233B 19.13
BioMarin Pharmaceutical (BMRN) United States $22.932B 207.88
Genmab (GNMSF) Denmark $21.757B 64.60
Alnylam Pharmaceuticals (ALNY) United States $18.345B 0.00
BeiGene (BGNE) Cayman Islands $15.540B 0.00
BioNTech SE (BNTX) Germany $14.845B 0.00
Exact Sciences (EXAS) United States $13.905B 0.00
Sarepta Therapeutics (SRPT) United States $13.255B 0.00
Galapagos (GLPG) Belgium $13.120B 38.59
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
ARGENX SE-ADR (ARGX) Netherlands $11.899B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.065B 27.23
Bio-Techne Corp (TECH) United States $10.602B 70.04
QIAGEN (QGEN) Netherlands $10.146B 29.50
Immunomedics (IMMU) United States $9.767B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.739B 0.00
Guardant Health (GH) United States $8.278B 0.00
Exelixis (EXEL) United States $7.415B 26.00
SWEDISH ORP BIO (BIOVF) Sweden $6.944B 17.28
Repligen (RGEN) United States $6.730B 118.05
Ascendis Pharma (ASND) Denmark $6.718B 0.00
Adaptive Biotechnologies (ADPT) United States $6.159B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.826B 125.36
Novavax (NVAX) United States $5.581B 0.00
Vir Biotechnology (VIR) United States $5.565B 0.00
Acceleron Pharma (XLRN) United States $5.419B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.246B 0.00
Zai Lab (ZLAB) China $5.199B 0.00
Reata Pharmaceuticals (RETA) United States $5.189B 0.00
Mirati Therapeutics (MRTX) United States $5.055B 0.00
Emergent Biosolutions (EBS) United States $4.953B 32.47
MyoKardia (MYOK) United States $4.347B 0.00
MorphoSys AG (MOR) Germany $4.340B 33.66
China Biologic Products (CBPO) China $4.266B 23.72
Blueprint Medicines (BPMC) United States $4.247B 0.00
Global Blood Therapeutics (GBT) United States $4.226B 0.00
Amicus Therapeutics (FOLD) United States $4.079B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.959B 0.00
NeoGenomics (NEO) United States $3.825B 279.31
Halozyme Therapeutics (HALO) United States $3.802B 0.00
Bluebird Bio (BLUE) United States $3.682B 0.00
Inovio Pharmaceuticals (INO) United States $3.679B 0.00
Arena Pharmaceuticals (ARNA) United States $3.310B 0.00
Alkermes (ALKS) Ireland $3.181B 62.63
Deciphera Pharmaceuticals (DCPH) United States $3.057B 0.00
Denali Therapeutics (DNLI) United States $2.833B 0.00
Insmed (INSM) United States $2.826B 0.00
Fate Therapeutics (FATE) United States $2.824B 0.00
Amarin (AMRN) Ireland $2.560B 0.00
PHARMA MAR SA (PHMMF) Spain $2.390B 0.00
Twist Bioscience (TWST) United States $2.304B 0.00
Viela Bio (VIE) United States $2.162B 0.00
UniQure (QURE) Netherlands $2.112B 0.00
Principia Biopharma (PRNB) United States $1.947B 0.00
Editas Medicine (EDIT) United States $1.905B 0.00
Alector (ALEC) United States $1.901B 0.00
Eidos Therapeutics (EIDX) United States $1.881B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.877B 0.00
Ligand Pharmaceuticals (LGND) United States $1.801B 70.13
Forma Therapeutics Holdings (FMTX) United States $1.729B 0.00
Adverum Biotechnologies (ADVM) United States $1.697B 0.00
I-Mab (IMAB) China $1.638B 0.00
Sorrento Therapeutics (SRNE) United States $1.625B 0.00
Intra-Cellular Therapies (ITCI) United States $1.623B 0.00
Zymeworks (ZYME) Canada $1.598B 0.00
Beam Therapeutics (BEAM) United States $1.574B 0.00
Cytokineticsorporated (CYTK) United States $1.553B 0.00
Sangamo Therapeutics (SGMO) United States $1.534B 0.00
Epizyme (EPZM) United States $1.533B 0.00
Mesoblast (MESO) Australia $1.526B 0.00
Mersana Therapeutics (MRSN) United States $1.512B 0.00
Zealand Pharma (ZEAL) Denmark $1.454B 0.00
Revance Therapeutics (RVNC) United States $1.446B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.445B 0.00
REGENXBIO (RGNX) United States $1.429B 0.00
NantKwest (NK) United States $1.388B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
Akcea Therapeutics (AKCA) United States $1.343B 0.00
Arvinas (ARVN) United States $1.340B 0.00
NGM Biopharmaceuticals (NGM) United States $1.314B 0.00
Coherus BioSciences (CHRS) United States $1.267B 8.84
Intellia Therapeutics (NTLA) United States $1.262B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.211B 0.00
Arcus Biosciences (RCUS) United States $1.173B 0.00
Compugen (CGEN) Israel $1.114B 0.00
Athenex (ATNX) United States $1.054B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.988B 0.00
Alcobra (ARCT) United States $0.967B 0.00
VBI Vaccines (VBIV) United States $0.939B 0.00
Retrophin (RTRX) United States $0.869B 0.00
Myriad Genetics (MYGN) United States $0.853B 44.00
Heska (HSKA) United States $0.847B 0.00
Dynavax Technologies (DVAX) United States $0.846B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.825B 0.00
Pharming Group (PHGUF) Netherlands $0.814B 21.67
Morphic Holding (MORF) United States $0.782B 0.00
Castle Biosciences (CSTL) United States $0.755B 0.00
Intrexon (PGEN) United States $0.744B 0.00
Cellectis S.A (CLLS) France $0.738B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.715B 0.00
Frequency Therapeutics (FREQ) United States $0.712B 0.00
Codexis (CDXS) United States $0.702B 0.00
Vericel (VCEL) United States $0.701B 129.50
ZIOPHARM Oncology Inc (ZIOP) United States $0.696B 0.00
Kadmon Holdings (KDMN) United States $0.687B 0.00
Agenus (AGEN) United States $0.656B 0.00
Cue Biopharma (CUE) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Autolus Therapeutics (AUTL) United Kingdom $0.640B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.632B 5.42
AnaptysBio (ANAB) United States $0.615B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
MiMedx (MDXG) United States $0.580B 0.00
Kala Pharmaceuticals (KALA) United States $0.572B 0.00
Athersys (ATHX) United States $0.570B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.556B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.553B 0.00
Cel-Sci (CVM) United States $0.547B 0.00
Syros Pharmaceuticals (SYRS) United States $0.545B 0.00
Clovis Oncology (CLVS) United States $0.515B 0.00
NextCure (NXTC) United States $0.500B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.496B 0.00
UROGEN PHARMA (URGN) United States $0.494B 0.00
Anika Therapeutics (ANIK) United States $0.494B 15.88
AC Immune SA (ACIU) Switzerland $0.493B 0.00
Scholar Rock Holding (SRRK) United States $0.490B 0.00
Prothena (PRTA) Ireland $0.482B 0.00
Protagonist Therapeutics (PTGX) United States $0.480B 0.00
DBV Technologies S.A (DBVT) France $0.472B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.466B 0.00
MeiraGTx Holdings (MGTX) United States $0.453B 0.00
Merus (MRUS) Netherlands $0.448B 0.00
Geron (GERN) United States $0.435B 0.00
Precision BioSciences (DTIL) United States $0.427B 0.00
BioDelivery Sciences (BDSI) United States $0.417B 21.90
Puma Biotechnology (PBYI) United States $0.403B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.401B 0.00
Seres Therapeutics (MCRB) United States $0.399B 0.00
MannKind (MNKD) United States $0.386B 0.00
CytomX Therapeutics (CTMX) United States $0.382B 0.00
Avid Bioservices (CDMO) United States $0.380B 0.00
Kamada (KMDA) Israel $0.380B 15.81
Albireo Pharma (ALBO) United States $0.379B 0.00
OSMOTICA PHARM (OSMT) United States $0.361B 0.00
WAVE Life Sciences (WVE) Singapore $0.357B 0.00
Affimed (AFMD) Germany $0.351B 0.00
ANI Pharmaceuticals (ANIP) United States $0.326B 6.33
PDL BioPharma (PDLI) United States $0.322B 283.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
ChromaDex (CDXC) United States $0.307B 0.00
Prometic Life Sciences (LMNL) Canada $0.301B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.301B 0.00
Cellular Biomedicine (CBMG) United States $0.295B 0.00
Menlo Therapeutics (MNLO) United States $0.283B 0.00
Abeona Therapeutics (ABEO) United States $0.280B 0.00
Spero Therapeutics (SPRO) United States $0.280B 0.00
Celldex Therapeutics (CLDX) United States $0.280B 0.00
Pfenex (PFNX) United States $0.274B 0.00
IBio (IBIO) United States $0.270B 0.00
Gritstone Oncology (GRTS) United States $0.264B 0.00
Northwest Biotherapeutics (NWBO) United States $0.259B 0.00
ADMA Biologics Inc (ADMA) United States $0.248B 0.00
IVERIC Bio (ISEE) United States $0.247B 0.00
Dyadic (DYAI) United States $0.246B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.242B 0.00
Five Prime Therapeutics (FPRX) United States $0.238B 0.00
Selecta Biosciences (SELB) United States $0.236B 0.00
Fortress Biotech (FBIO) United States $0.236B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.236B 0.00
Verastem (VSTM) United States $0.236B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Pluristem Therapeutics (PSTI) Israel $0.220B 0.00
Aduro Biotech (ADRO) United States $0.215B 0.00
Aptinyx (APTX) United States $0.213B 0.00
XOMA (XOMA) United States $0.213B 0.00
Liquidia Technologies (LQDA) United States $0.211B 0.00
GENFIT S.A (GNFT) France $0.204B 0.00
Sutro Biopharma (STRO) United States $0.203B 0.00
Strongbridge Biopharma (SBBP) United States $0.199B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.198B 2.98
Exicure (XCUR) United States $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
Bellus Health (BLU) Canada $0.187B 0.00
ARAVIVE, INC (ARAV) United States $0.181B 0.00
Theratechnologies (THTX) Canada $0.175B 0.00
Trevena (TRVN) United States $0.174B 0.00
Aytu Bioscience (AYTU) United States $0.162B 0.00
CorMedix Inc (CRMD) United States $0.160B 0.00
Cyclerion Therapeutics (CYCN) United States $0.159B 0.00
Applied Genetic Technologies (AGTC) United States $0.157B 0.00
Kindred Biosciences (KIN) United States $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
Biofrontera AG (BFRA) Germany $0.149B 0.00
TELA Bio (TELA) United States $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
VolitionRX (VNRX) United States $0.134B 0.00
Lumos Pharma (LUMO) United States $0.134B 0.00
Celyad SA (CYAD) Belgium $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.132B 0.00
Enzo Biochem (ENZ) United States $0.128B 0.00
Arbutus Biopharma (ABUS) United States $0.128B 0.00
Oncobiologics (OTLK) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.125B 0.00
Palatin Technologies (PTN) United States $0.121B 3.12
Lineage Cell Therapeutics (LCTX) United States $0.118B 0.00
Celsion (CLSN) United States $0.117B 0.00
AIT Therapeutics (XAIR) United States $0.117B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.116B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
AquaBounty Technologies (AQB) United States $0.111B 0.00
Eton Pharmaceuticals (ETON) United States $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.102B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
Cardiff Oncology (CRDF) United States $0.095B 0.00
Cocrystal Pharma (COCP) United States $0.095B 0.00
DiaMedica Therapeutics (DMAC) United States $0.095B 0.00
Unum Therapeutics (UMRX) United States $0.094B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.088B 0.00
Organovo Holdings (ONVO) United States $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
SESEN BIO, INC (SESN) United States $0.077B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
Proteostasis Therapeutics (PTI) United States $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.067B 0.00
Synlogic (SYBX) United States $0.067B 0.00
AnPac Bio-Medical Science (ANPC) China $0.065B 0.00
Stealth BioTherapeutics (MITO) United States $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Signal Genetics (MGEN) United States $0.051B 0.00
Curis (CRIS) United States $0.046B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Edesa Biotech (EDSA) Canada $0.043B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Prima BioMed (IMMP) Australia $0.041B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Cesca Therapeutics (THMO) United States $0.033B 0.00
Spherix (AIKI) United States $0.032B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.032B 0.00
OvaScience (MLND) United States $0.032B 0.00
Chanticleer Holdings (SONN) United States $0.031B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
BioPharmX (TMBR) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
IMMURON (IMRN) Australia $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.021B 0.00
BioCardia (BCDA) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
VIVUS (VVUS) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00